Stock Exchange Communication

Trading Window Closure September 30, 2025

Appointment of Investor Relations Agency

Amendment in Windlas Plan 2025

Outcome of Nomination and Remuneration Committee Meeting

24th AGM Voting Result

Proceedings of 24th AGM held as on July 28,2025

INTIMATION OF RECORD DATE

ANNUAL REPORT FOR FY 2024-25

24th AGM NOTICE

Trading Window Closure jUNE 30, 2025

Change in management 22052025

Outcome of BM 22052025

Trading Window Closure March 31, 2025

Change-in-Management-11-February-2025

Press Release 10012025

ESOP Allotment January 3, 2025

Change of name of the Company’s Registrar & Share Transfer Agent

Trading Window Closure December 31, 2024

Trading Window Closure June 30, 2024

Trading Window Closure September 30, 2024

23rd AGM Voting Results

Outcome of 23rd AGM held as on September 24, 2024

Intimation of Book Closure August 29, 2024

23rd AGM Notice

Annual Report for FY 2023-24

ESOP Allotment 10 June 2024

Audio Transcript Q4 FY 24

Change in Management 20 May 2024

Regulation 74(5) March 31, 2024

Reg 7(3) March 31, 2024

Press Release 02042024

22nd AGM Voting Results”

Trading Window 28 March 2024

Audio Transcript Q3 FY 24

Reconciliation of Share Capital Q3 24

As Certificate under Regulation 74(5) for Q3 FY24.

Trading Window Closure 31-12-2023

Recording of Conference Call

Reconciliation of Share Capital Q2 FY 24.

As Certificate under Regulation 74 (5) for Q2 FY 24.

Closure of Trading Window September 30, 2023

Con call for Financial Performance – January 29,2022.

Invite for Investor Meeting September 9, 2021.

Closure of Trading Window September 30, 2021.

Certificate under Reg 74(5)

Reg 74(5) announcement 10 April 2023

Outcome of 22nd AGM held as on September 12, 2023.

Annual Report for FY 2022-23.

22nd AGM Notice

Intimation of Book Closure August 16, 2023

Intimation of Investor Call on Unaudited Financial Results for Q1 FY 24, August 09, 2023”.

Board Meeting Intimation – August 8, 2023

Intimation of Schedule of Analyst & Institutional Investor meeting- July 12, 2023

Intimation of Schedule of Analyst & Institutional Investor meeting- July 11, 2023

Intimation of Schedule of Analyst & Institutional Investor meeting- July 7, 2023

Closure of Trading Window June 30, 2023

June 17th 2023- Clarification to stock Exchange for significant increase in volume in shares of company

Board Meeting Intimation April 28, 2023

Large Entity Disclosure 24 Apr 2023

Reg 7(3) 11032023 11 Apr 2023

Trading Window Closure 31 March 2023

CEO Press Release

Outcome of the Board Meeting February 08, 2023

Schedule of Conference Call to discuss financial performance for quarter ended December 31, 2022

Certificate under Regulation 74(5)- January 12, 2023.

Trading Window Closure 30-12-2022.

November 09,2022 Corrigendum to the Outcome of Board Meeting

Buyback Public Announcement

Closure of Trading Window 30th September 2022.

Intimation of schedule of analyst & Institutional Investor Meeting- 22nd September 2022.

21st AGM Voting results.

21st AGM Proceedings.

Intimation of schedule of analyst & Institutional Investor Meeting- 8th September 2022.

INVESTOR MEETING -1st September 2022

Regulation 34 Annual report FY 21-22 intimation.

Newspaper advertisement of 21st AGM

Q1 FY22-23 Earning Call

Financial Results Q1 FY 22-23

Schedule of Conference Call to discuss financial performance for quarter ended June 30, 2022.

Virtual Meeting - Exchange Intimation

Trading Window Closure Q1

Investor Conference

Annual Secretarial Compliance Report for the year ended March 31, 2022

Board Meeting Outcome 12052022

Press Release GMP

Initial Disclosure

Investor meeting 30th March 2022

Investor meeting 31st March 2022

Investor meeting 17 Feb 2022

Intimation of Schedule of Analyst / Institutional Investor meetings

Investor meeting with the exchanges.

Reg 74(5) certificate

Closure of trading window

Investec conference

Closure of trading window

3

Subscribe & Get More Information

Windlas Biotech Limited: Pioneering Pharma Solutions Globally | Empowering Healthier Lives | Authenticity and Affordability Redefined

About

Expertise

Services

Brands

Contact Info

Copyright ©2024 Windlas. All Rights Reserved.

About

Expertise

Services

Brands

About

Tel: 0124 282 1030
Tel: +91 135 6608000
Email: info@windlasbiotech.com,
grievance@windlasbiotech.com

©2023 Windlas. All Rights Reserved.

About

Services

Facilities

Products

Investor Relations

CSR

Career

Blog

Contact us

Windlas Biotech Limited
Corporate Identification Number : L74899UR2001PLC033407

Empowering innovation at Windlas Biotech – where advanced research meets sustainable solutions. Driven by science, we are dedicated to transforming health through pioneering biotech advancements and excellence in research and development.